Shares of 160 Health International (02656.HK) soared 152.48% in their Hong Kong trading debut on Wednesday, showcasing robust investor appetite for the healthcare technology sector. The digital healthcare integrated services provider's stock opened at HK$29.98, compared to its initial public offering (IPO) price of HK$11.89 per share.

The spectacular first-day performance follows an immensely popular IPO that saw overwhelming demand from investors. According to the company's allocation results, the Hong Kong public offering portion was oversubscribed by a staggering 751.77 times, while the international offering was oversubscribed by 1.92 times. 160 Health raised net proceeds of approximately HK$316 million (US$40.4 million) from the global offering of 33.6455 million shares.

Market analysts attribute the strong debut to several factors, including the company's positioning in the fast-growing digital healthcare market and the recent wave of enthusiasm for new listings in Hong Kong. However, some experts caution that the company's financial performance, including recent losses and cash flow challenges, may warrant careful consideration by long-term investors. As the dust settles on this explosive debut, all eyes will be on 160 Health's ability to leverage its market position and deliver on its growth strategies in the competitive healthcare technology landscape.